By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile



One Alewife Center

Cambridge  Massachusetts  02140  U.S.A.
Phone: 617-547-5421 Fax: 617-547-5442



Company News
Selventa Strengthens Intellectual Property for System Diagnostics (SysDx™) Approach to Personalized Medicine 5/8/2013 10:57:42 AM
Seegene, Inc. and Selventa Form Strategic Collaboration to Develop Novel Molecular Diagnostics (MoDx) 4/23/2013 11:55:06 AM
Selventa Developing Powerful New Class of Multi-omic Based Diagnostic Test for Autoimmune Disease and Cancer 1/22/2013 9:26:02 AM
Selventa to Participate in a High Profile Panel on Companion Diagnostics at BIO-Europe 2012 11/5/2012 9:42:36 AM
Selventa CEO David de Graaf Named as one of PharmaVOICE Magazine's "100 Most Inspiring People in the Life Sciences" 8/9/2012 10:27:18 AM
Selventa Releases OpenBEL as Open Source and Encourages the Community to Participate in an OpenBEL Consortium 6/18/2012 10:22:28 AM
Selventa Names William Hayes as Senior Vice President of Platform Development 4/17/2012 10:16:13 AM
Selventa Announces a Research Agreement to Understand Mechanisms of Disease 2/27/2012 6:32:19 AM
Selventa Granted Patent for Discovery of Biomarker Profiles 1/23/2012 6:35:08 AM
Selventa and Linguamatics Ltd Announce Strategic Partnership to Provide a Complete Pipeline of Scientific Knowledge Extraction to their Life Science Partners 10/31/2011 6:54:37 AM